Curiel D.T.
19
Coauthors
3
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 4 |
| Genética | 2 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 2 |
| Microorganismos, hongos y algas | 1 |
| Farmacología y terapéutica | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 3 |
| Google Scholar | 3 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| REBECA GONZALEZ-PASTOR | 3 |
| Dmitriev I.P. | 2 |
| Lu Z.H. | 2 |
| Kashentseva E.A. | 2 |
| Goedegebuure S.P. | 2 |
| Shoemaker C.B. | 1 |
| St. Croix B. | 1 |
| Seaman S. | 1 |
| Lee M. | 1 |
| Tremblay J.M. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer
ReviewAbstract: Ovarian cancer is the leading cause of death among women with gynecological cancer, with an overallPalabras claves:Autores:Curiel D.T., Goedegebuure S.P., REBECA GONZALEZ-PASTORFuentes:googlescopusDefining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents
ArticleAbstract: Background: Virotherapy represents a promising approach for ovarian cancer. In this regard, conditioPalabras claves:Adenovirus, Anti-tumor immunization, CRAd, ID8, Ovarian Cancer, VirotherapyAutores:Ashshi A.M., Curiel D.T., Dmitriev I.P., El-Shemi A.G., Goedegebuure S.P., Kashentseva E.A., Lu Z.H., Podhajcer O.L., REBECA GONZALEZ-PASTORFuentes:googlescopusAdvanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
ArticleAbstract: For the developing field of gene therapy the successful address of the basic requirement effective gPalabras claves:Adenoviral vectors (Ad), Camelid single domain antibody (sdAb), CD276 [B7-H3], Gene delivery, Human epithelial ovarian cancer cell (SKOV3.ip1), Ovarian Cancer (OvCa) xenograft mouse modelAutores:Curiel D.T., Dmitriev I.P., Kashentseva E.A., Lee M., Lu Z.H., REBECA GONZALEZ-PASTOR, Seaman S., Shoemaker C.B., St. Croix B., Tremblay J.M.Fuentes:googlescopus